- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03084133
Impact of EDUcation Strategy on Patients With COLorectal CANCER or Advanced Adenoma in the Detection of Colorectal Cancer of Their First-degree Relatives (EDUCANCOLAGE)
Impact of EDUcation Strategy on Patients With COLorectal CANCER or Advanced Adenoma in the Detection of Colorectal Cancer of Their First-degree Relatives - Randomized, Multicenter Cluster Test
The relative risk of colorectal cancer (CRC) is increased in first-degree relatives of patients with CRC or advanced adenoma. In the high-risk CCR population defined by a family history at the first stage of CRC or advanced adenoma before age 60, total colonoscopy is the recommended screening test. In France, the rate of screening colonoscopy in this population at high risk of CRC is insufficient, which limits the effectiveness of this targeted screening.
The main reason for this low participation rate is that most patients undergoing RCC or advanced adenoma are unaware of the family implications of their diagnosis and therefore reluctant to disseminate this information to their patients Related matters. The need for a better perception of the personal risk of CRC in first-degree relatives of patients with CRC or advanced adenoma, with the expected coronary adherence to increasing screening, requires a good understanding of risk through Clear, adapted and comprehensible information that can be relayed personally by the case-index.
The objective of this project is to develop a personalized prevention and screening program for the JRC in order to meet the needs of the relatives of the sick. The means of intervention that will be implemented respond to the need to better take into account the level of CRC risk in a family-based CRC screening and prevention approach adapted to a high-risk CRC group characterized by Family history at the first stage of CRC or advanced adenoma and, consequently, to improve the information of the subjects concerned by screening and prevention of CRC.
The aim of the case-index education is to induce its intervention with its relatives to promote CCR screening. The use of the index case, as a means of providing information to relatives, implies an educational and psychological approach, based on evidence, but adapted and personalized.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Angers, France
- Service d'Hépatogastro-entérologie CHU ANGERS
-
Blois, France, 41 000
- Service d'Hépatogastro-entérologie CHG BLOIS
-
Dreux, France
- Service d'Hépatogastro-entérologie CHG de DREUX
-
Loches, France
- Service de Médecine CHG de Loches
-
Nantes, France
- Service d'Hépatogastro-entérologie CHU de NANTES
-
Orleans, France, 45067
- Service d'Hépatogastro-entérologie CHR d'Orléans
-
Poitiers, France, 86 000
- Service d'Hépatogastro-entérologie CHU POITIERS
-
Tours, France, 37044
- Service d'Hépatogastro-entérologie CHRU de TOURS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
List of inclusion criteria
Index case:
- Patients with colorectal adenocarcinoma or advanced adenoma diagnosed (definition of advanced adenoma (Winawer, 2006): adenoma of diameter ≥ 10 mm and / or severe dysplasia and / or with a villous contingent).
- Patients with at least one relative of the first degree belonging to the target population of the screening strategy evaluated (between 40 and 75 years of age and less than 10 years of age of the case-index) and residing in France.
- Affiliation of the patient to a social security scheme (including CMU).
- Understanding of the French language.
Related:
- They correspond to the target population at high risk of colorectal cancer targeted by this program of promotion of colonoscopy screening:
- Subjects related to 1st degree to the index case and in contact with it.
- Age between 40 and 75 years of age or less than 10 years of age of the index case.
- Resides in France
List of exclusion Criteria :
Index case :
- Chronic inflammatory bowel disease.
- Genetic predisposition syndrome identified with colorectal cancer (Lynch syndrome, familial polyposis linked to the APC and MYH genes).
- Patient's knowledge of a first-degree relative with colorectal adenocarcinoma or advanced adenoma.
- Isolated patient of his / her first-degree relatives and not wishing to re-establish contact with them.
- Advanced colorectal cancer with a life expectancy <6 months and / or a WHO ≥ 2 general condition.
- Transmission of information to the family already carried out.
Related :
- Not applicable
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Therapeutic Education Strategy
Means a screening information and education system in which the particularities of the index cases likely to require adaptation of the device will be collected, analyzed and taken into account. Intervention 'Therapeutic Education Strategy' |
In the experimental arm of the study ("intervention group"), a screening information and education system will be implemented.
The particularities of the index cases likely to require an adaptation of the device will be collected, analyzed and taken into account (level of health literacy, socio-economic status, level of education, professional activity ...).
The analysis and intervention frameworks derived from theories on health behaviors will be mobilized (theory of reasoned action, theory of planned behaviors) and applied in order to reinforce the "intention" of the target audience.
The analysis and intervention frameworks resulting from the educational sciences will be integrated with a "competence" approach (Aizen, 1991, Denovel, Dufour, Prochaska, 1983, Le Boterf, 2002).
|
No Intervention: Control group
Provision of information on the need for screening colonoscopy in first-degree relatives of case-index patients by the practitioner taking charge of the index case according to its usual practice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participation rate in screening colonoscopy for first-degree relatives of patients with RCC or advanced adenoma.
Time Frame: 12 MONTHS
|
Participation rate in screening colonoscopy for first-degree relatives of patients with RCC or advanced adenoma.
|
12 MONTHS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychological determinants (quality of relationship with relatives, motivation to inform relatives) that can condition the enrollment in the education program.
Time Frame: 12 MONTHS
|
Psychological determinants (quality of relationship with relatives, motivation to inform relatives) that can condition the enrollment in the education program.
|
12 MONTHS
|
Social and demographic factors in index cases associated with screening colonoscopy in related subjects: age, sex, educational level, socio-professional category.
Time Frame: 12 MONTHS
|
Social and demographic factors in index cases associated with screening colonoscopy in related subjects: age, sex, educational level, socio-professional category.
|
12 MONTHS
|
Social and demographic factors associated with screening colonoscopy in related subjects: age, sex, educational level, socio-professional category.
Time Frame: 12 MONTHS
|
Social and demographic factors associated with screening colonoscopy in related subjects: age, sex, educational level, socio-professional category.
|
12 MONTHS
|
How to access screening colonoscopy: pathway (public or private), direct access to the gastroenterologist or through the attending physician.
Time Frame: 12 MONTHS
|
How to access screening colonoscopy: pathway (public or private), direct access to the gastroenterologist or through the attending physician.
|
12 MONTHS
|
Time to access the colonoscopy (time between the procedure and the completion of the screening colonoscopy).
Time Frame: 2 MONTHS
|
Time to access the colonoscopy (time between the procedure and the completion of the screening colonoscopy).
|
2 MONTHS
|
Rate of colorectal cancer.
Time Frame: 12 MONTHS
|
Rate of colorectal cancer.
|
12 MONTHS
|
Rate of advanced adenomas.
Time Frame: 12 MONTHS
|
Rate of advanced adenomas.
|
12 MONTHS
|
Detection rate of scallop lesions.
Time Frame: 12 MONTHS
|
Detection rate of scallop lesions.
|
12 MONTHS
|
Rate of complications in screening colonoscopies.
Time Frame: 12 MONTHS
|
Rate of complications in screening colonoscopies.
|
12 MONTHS
|
Quality criteria for screening colonoscopy using the following parameters: visualization rate of the bottom of the colon, the withdrawal time of the colonoscope (Withdrawal time), quality of the colic preparation using the Boston scale.
Time Frame: 12 MONTHS
|
Quality criteria for screening colonoscopy using the following parameters: visualization rate of the bottom of the colon, the withdrawal time of the colonoscope (Withdrawal time), quality of the colic preparation using the Boston scale.
|
12 MONTHS
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: CAROLI BOSC Françis- Xavier, Pr, University Hospital, Angers
- Principal Investigator: MATYSIAK-BUDNIK Tamara, Pr, CHU Nantes
- Principal Investigator: LANDAU Alain, Dr, CHG DREUX
- Principal Investigator: GARGOT Denis, Dr, CHG BLOIS
- Principal Investigator: BARBIEUX Jean- Pierre, Dr, CHG LOCHES
- Principal Investigator: TOUGERON David, Pr, CHU Poitiers
- Principal Investigator: LEGOUX Jean- Louis, Dr, CHR Orleans
- Principal Investigator: BOURGEOIS Hugues, Dr, Clinic Victor Hugo LE MANS
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Colonic Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Colorectal Neoplasms
- Adenoma
Other Study ID Numbers
- INCA14-TL/EDUCANCOLAGE
- 2015-A01514-45 (Other Identifier: ID RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Colorectal
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
Sidney Kimmel Cancer Center at Thomas Jefferson...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States
Clinical Trials on Therapeutic Education Strategy
-
Olivier MichelUnknownChronic Obstructive Respiratory DiseasesBelgium, Vietnam
-
Chang Gung Memorial HospitalNot yet recruitingSelf Efficacy | Nursing Caries | Simulation of Physical Illness | Intensive Care Unit Delirium
-
Roy La Touche ArbizuUniversidad Autonoma de Madrid; Centro Universitario La Salle; Servicio Madrileño...UnknownLow Back Pain | Chronic Nonspecific Low Back PainSpain
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulCompletedPulmonary Tuberculosis | Extra Pulmonary TuberculosisBrazil
-
Nantes University HospitalTerminated
-
Wen-Yi ChaoEnrolling by invitationKnowledge, Attitudes, Practice | Self Efficacy | LearningTaiwan
-
University of MichiganCompleted
-
Assistance Publique - Hôpitaux de ParisCentre Leon Berard; Ministry of Health, France; Université Montpellier; Telecom... and other collaboratorsUnknownKidney Transplantation | End-stage Renal Disease | Dialysis
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Beauvais HospitalNot yet recruitingNutrition Aspect of Cancer